Detalles de la búsqueda
1.
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation.
J Thromb Thrombolysis
; 45(1): 106-113, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29022213
2.
Laboratory and clinical risk assessment to treat myelodysplatic syndromes.
Clin Chem Lab Med
; 54(9): 1411-26, 2016 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26812791
3.
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated with Thrombopoietin Receptors Agonists.
J Thromb Thrombolysis
; 50(4): 903-907, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347510
4.
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function.
Ann Hematol
; 93(9): 1523-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24711171
5.
Ibrutinib related bleeding complications in elderly patients with B cell malignancies.
J Thromb Thrombolysis
; 48(4): 694-696, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240431
6.
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
J Thromb Thrombolysis
; 47(1): 155-156, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30478722
7.
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population.
Blood
; 118(17): 4554-60, 2011 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21750313
8.
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease.
Apoptosis
; 17(3): 289-304, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22160861
9.
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
Lancet
; 376(9758): 2075-85, 2010 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21146205
10.
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma.
Blood
; 114(25): e20-6, 2009 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19846888
11.
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
Genes Chromosomes Cancer
; 48(6): 521-31, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19306352
12.
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
Genes Chromosomes Cancer
; 48(7): 603-14, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19396863
13.
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study.
Clin Lymphoma Myeloma Leuk
; 20(8): e461-e467, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32507387
14.
Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
Carcinogenesis
; 30(8): 1330-5, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19531770
15.
In vitro anti-leukaemia activity of sphingosine kinase inhibitor.
Br J Haematol
; 144(3): 350-7, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19036099
16.
Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.
Hematol Oncol
; 27(1): 23-30, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18759374
17.
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
N Engl J Med
; 353(10): 977-87, 2005 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-16148283
18.
The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia.
Am J Clin Pathol
; 130(3): 336-42, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18701405
19.
The impact of anaemia, transfusion dependency, comorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes.
Med Oncol
; 35(3): 33, 2018 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29417235
20.
Management of anemia in low-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents.
Med Oncol
; 35(5): 76, 2018 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29675620